Difficulty: Medium
Average Score: 65%
Practice
The anti-diuretic action of vasopressin is mediated via
Correct answer
B
Rationale
In the context of CNS stimulants drugs pharmacology, understanding the mechanism of action of vasopressin is crucial for healthcare professionals. The correct answer is B) V2 receptor because the anti-diuretic action of vasopressin is primarily mediated through V2 receptors located on the basolateral membrane of the renal collecting duct. Activation of V2 receptors leads to the insertion of aquaporin-2 water channels into the apical membrane, increasing water reabsorption and reducing urine volume.
Option A) V1 receptor is incorrect because V1 receptors predominantly mediate the vasoconstrictive effects of vasopressin in the vascular smooth muscle, rather than its anti-diuretic action. Option C) Both of the above is incorrect because only the V2 receptor is responsible for the anti-diuretic effect of vasopressin, while V1 receptors serve a different physiological function.
Educationally, understanding the specific receptor mediation of vasopressin's actions is essential for optimizing therapeutic outcomes and minimizing adverse effects when using CNS stimulants drugs. Healthcare providers need to differentiate between V1 and V2 receptors to target specific actions of vasopressin in various clinical scenarios, such as treating diabetes insipidus or managing hypotension in septic shock. This knowledge enhances clinical decision-making and ensures safe and effective pharmacological interventions.
Option A) V1 receptor is incorrect because V1 receptors predominantly mediate the vasoconstrictive effects of vasopressin in the vascular smooth muscle, rather than its anti-diuretic action. Option C) Both of the above is incorrect because only the V2 receptor is responsible for the anti-diuretic effect of vasopressin, while V1 receptors serve a different physiological function.
Educationally, understanding the specific receptor mediation of vasopressin's actions is essential for optimizing therapeutic outcomes and minimizing adverse effects when using CNS stimulants drugs. Healthcare providers need to differentiate between V1 and V2 receptors to target specific actions of vasopressin in various clinical scenarios, such as treating diabetes insipidus or managing hypotension in septic shock. This knowledge enhances clinical decision-making and ensures safe and effective pharmacological interventions.